Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H21NO3 |
Molecular Weight | 347.407 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=C(C)NC(C)=C1C(=O)C2=CC=CC=C2CC3=CC=CC=C3
InChI
InChIKey=MDMWHKZANMNXTF-UHFFFAOYSA-N
InChI=1S/C22H21NO3/c1-14-19(20(15(2)23-14)22(25)26-3)21(24)18-12-8-7-11-17(18)13-16-9-5-4-6-10-16/h4-12,23H,13H2,1-3H3
Molecular Formula | C22H21NO3 |
Molecular Weight | 347.407 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12842134
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12842134
FPL 64176 is a nondihydropyridine L-type calcium channel activator with high efficacy properties. It is being used as a tool for studying the physiological roles and disorders of L-type channels, identification of L-type currents within the mix of channel subtypes and for increasing the contractility of smooth and cardiac muscle.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095229 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12842134 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1719369
The pharmacological, radioligand binding and electrophysiological properties of FPL 64176 were studied in rat tail artery, cardiac membranes, and A7r5 smooth muscle cells. FPL 64176 induced a contractile response, with an EC50 value of 2.11 x 10(-7) M. The maximum tension response to FPL 64176 was approximately 2-fold higher than that to (S)-Bay K 8644. FPL 64176 showed no significant inhibitory activity at concentrations up to 10(-5) M. The Ca2+ channel antagonists nifedipine, verapamil and diltiazem noncompetitively antagonized and completely relaxed the responses induced by FPL 64176. FPL 64176 weakly inhibited (+)-[3H]PN 200-110, [3H]D888, and [3H]TA-3090 binding in rat cardiac membranes, with IC50 values of 1.04 x 10(-5) M and 7.03 x 10(-6) M for inhibition of (+)-[3H]PN 200-110 and [3H]TA-3090 binding, respectively, and with 23% inhibition of [3H]D888 binding at a FPL 64176 concentration of 1 x 10(-5) M. The results suggested that FPL 64176 had a mechanism and site of action that is distinct from those for (S)-Bay K 8644.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:59:31 GMT 2023
by
admin
on
Fri Dec 15 17:59:31 GMT 2023
|
Record UNII |
UU89L306PO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID40153064
Created by
admin on Fri Dec 15 17:59:31 GMT 2023 , Edited by admin on Fri Dec 15 17:59:31 GMT 2023
|
PRIMARY | |||
|
249982
Created by
admin on Fri Dec 15 17:59:31 GMT 2023 , Edited by admin on Fri Dec 15 17:59:31 GMT 2023
|
PRIMARY | |||
|
120934-96-5
Created by
admin on Fri Dec 15 17:59:31 GMT 2023 , Edited by admin on Fri Dec 15 17:59:31 GMT 2023
|
PRIMARY | |||
|
3423
Created by
admin on Fri Dec 15 17:59:31 GMT 2023 , Edited by admin on Fri Dec 15 17:59:31 GMT 2023
|
PRIMARY | |||
|
UU89L306PO
Created by
admin on Fri Dec 15 17:59:31 GMT 2023 , Edited by admin on Fri Dec 15 17:59:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |